Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Individual response varies, so choose a time that helps you manage side effects most effectively
Glutathione injections can work wonders on your skin
Commentary TennCares obesity medication coverage is a win for Tennesseans TennCare, Tennessees Medicaid program, recently committed to covering the cost of semaglutide medications to aid with weight loss
Weight loss treatment should be personalized
14.5 MOUNJARO Use in Combination with Metformin or Basal Insulin, or Both in Pediatric Patients 10 Years of Age and Older with Type 2 Diabetes Mellitus SURPASS-PEDS (NCT05260021) was a 30-week double-blind, placebo-controlled trial with a 22-week open-label extension that randomized 99 pediatric patients 10 years of age and older with type 2 diabetes mellitus with inadequate glycemic control on metformin (69%), or basal insulin (8%), or both (23%) to receive subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, or placebo once weekly as add-on therapy
